Members views sought for BNF for Children dose review
Use of naloxone for the reversal of respiratory and CNS depression resulting from opioid administration to mother during labour.
BNF for Children dose review: use of naloxone for the reversal of respiratory and CNS depression resulting from opioid administration to mother during labour.
The BNF for Children currently provides naloxone dosing for neonates for a number of indications - these are overdosage with opioids, reversal of postoperative respiratory depression, and reversal of respiratory depression and CNS depression resulting from opioid administration to mother during labour. This dosing is being reviewed, following a review of naloxone dosing for children aged 1 month and over, and adults.
The BNF is seeking BAPM members’ expert advice on the use of naloxone for the reversal of respiratory depression and CNS depression resulting from opioid administration to mother during labour.
BAPM members’ opinions are sought on the two questions on page 2 of the document below. Please send any thoughts to [email protected]
Deadline: 31 March.
BNF Dose Review document
